Amprius Confirms AMPX Common Stock & Warrants Listed on NYSE

TL;DR

**Amprius (AMPX) confirms its common stock and warrants are listed on the NYSE.**

AI Summary

Amprius Technologies, Inc. filed an 8-K on January 16, 2024, to update its registered securities. The filing confirms that its Common Stock, with a par value of $0.0001 per share, trades under the symbol AMPX on The New York Stock Exchange. Additionally, its Redeemable Warrants, each exercisable for one share of common stock at an exercise price of $11.50, trade under the symbol AMPX.W, also on The New York Stock Exchange. This filing is a routine update, providing clarity on the company's listed securities and their trading venues, which is important for investors to know where and how to trade their shares or warrants.

Why It Matters

This filing provides a clear, official record of Amprius Technologies' listed securities and their trading symbols and exchanges, which is fundamental information for any investor looking to buy or sell the company's stock or warrants.

Risk Assessment

Risk Level: low — This 8-K is a routine informational filing and does not introduce new financial risks or operational changes.

Analyst Insight

A smart investor would note this filing as a routine compliance update, confirming the trading details of AMPX common stock and warrants on the NYSE, but it doesn't provide new information to drive immediate investment decisions.

Key Numbers

• $0.0001 — Common Stock Par Value (The nominal value assigned to each share of common stock.)
• $11.50 — Warrant Exercise Price (The price at which each redeemable warrant can be converted into one share of common stock.)

Key Players & Entities

• Amprius Technologies, Inc. (company) — the registrant filing the 8-K
• $0.0001 (dollar_amount) — par value per share of common stock
• $11.50 (dollar_amount) — exercise price for each redeemable warrant
• January 16, 2024 (date) — date of earliest event reported and filing date
• The New York Stock Exchange (company) — exchange where securities are registered

FAQ

Key Financial Figures

• $0.0001 — ich registered Common stock, par value $0.0001 per share AMPX The New York Stock Excha
• $11.50 — of common stock at an exercise price of $11.50 AMPX.W The New York Stock Exchange In

Filing Documents

• ampx-20240116.htm (8-K) — 36KB
• ampriustech-berzeliusxexcl.htm (EX-10.1) — 27KB
• 0001899287-24-000002.txt ( ) — 239KB
• ampx-20240116.xsd (EX-101.SCH) — 3KB
• ampx-20240116_def.xml (EX-101.DEF) — 16KB
• ampx-20240116_lab.xml (EX-101.LAB) — 31KB
• ampx-20240116_pre.xml (EX-101.PRE) — 16KB
• ampx-20240116_htm.xml (XML) — 4KB

01 Other Events

Item 8.01 Other Events. On January 16, 2024, Amprius Technologies, Inc., a Delaware corporation ("Amprius"), announced its plans to broaden its product portfolio with new silicon anode battery platform – SiCore TM . In addition to this SiCore product platform, Amprius has also branded its existing silicon nanowire platform SiMaxx TM . The SiCore batteries are based on the innovative, proprietary material system developed by Berzelius (Nanjing) Co. Ltd., a Chinese corporation ("Berzelius"), which prior to February 2022 was a subsidiary of Amprius, Inc., a significant stockholder of Amprius, and are currently manufactured by toll manufacturing partners. Amprius expects to produce both SiCore and SiMaxx batteries at its large-scale factory in Colorado. To facilitate this product expansion, Amprius entered into an Exclusive Supply Agreement (the "Exclusivity Agreement") with Berzelius, pursuant to which Berzelius agreed, among other things, (i) to manufacture for, and sell exclusively to, Amprius its proprietary silicon anode materials in the United States, Canada or Mexico and (ii) to use best efforts to prioritize fulfillment of Amprius' forecasted orders, if any. The Exclusivity Agreement does not include any commercial terms, and the purchase of the materials under the Exclusivity Agreement by Amprius, if any, will be specified in written purchase orders mutually agreeable to the parties. The Exclusivity Agreement will remain in effect until it is mutually terminated by the parties. The foregoing description of the Exclusivity Agreement is not complete and is qualified in its entirety by reference to the full text of such agreement, which is attached hereto as Exhibit 99.1 to this report and incorporated herein by reference.

Forward-Looking Statements

Forward-Looking Statements This report includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "expect," "anticipate," "believe," "seek" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the batteries to be produced at Amprius' large-scale manufacturing facility and Amprius' ability to successfully expand its product offerings. These statements are based on various assumptions, whether or not identified in this report, and on the current expectations of Amprius' management and are not predictions of actual performance. Actual results could differ materially from these forward-looking statements as a result of certain risks and uncertainties. These forward-looking statements are subject to a number of risks and uncertainties, including market demands for SiCore batteries; the ability of Amprius to deliver high performance products to customers at acceptable prices and meet their demands via the toll manufacturing arrangements; Amprius' ability to reduce costs as it scales production; delays in permitting, construction and operation of production facilities; the ability of Amprius to establish manufacturing lines suitable for SiCore batteries at its Colorado facility; the ability of Amprius to meet costs targets when manufacturing SiCore batteries at its Colorado facility; third-party producers of Amprius batteries continuing to produce such batteries in the expected quantities and caliber and at the expected prices; Amprius' customers continuing to purchase batteries directly from Amprius; Amprius' liquidity position; risks related to the rollout of Amprius' busi

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 10.1* Exclusive Supply Agreement dated November 28, 2023, by and between the Company and Berzelius (Nanjing) Co. Ltd. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) *Certain schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule will be finished to the SEC upon request.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMPRIUS TECHNOLOGIES, INC. Date: January 16, 2024 By: /s/ Sandra Wallach Name: Sandra Wallach Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR